Krisztina Eva Sajosi’s journey from BIA-ALCL diagnosis to international advocacy is both powerful and deeply personal. Today we honor her resilience and commitment to raising global awareness about the hidden risks of breast implants, and her tireless efforts to ensure no woman faces this alone or uninformed.

If you're considering breast reconstruction after breast cancer, this article is a must-read. Carol Small shares her powerful story of regret, health complications, and the critical importance of informed consent.

The PIP breast implant scandal is back in the news thanks to 60 Minutes Australia. Read why this is a powerful reminder that without transparency and independent oversight, the same mistakes can happen again.

A major government just said the quiet part out loud. Cosmetic procedures, including breast implants, come with real risks, and now the UK is launching an official inquiry to investigate. Learn how you can help before the July 4th deadline.

BISA was featured in the Tampa Bay Times alongside brave survivors of BIA-ALCL who gathered in Tampa to advocate for a ban on textured implants, stronger cancer warnings, and national cancer reporting.

If you’ve had breast surgery, you may have had GalaFLEX mesh or the “internal bra” placed in your body without knowing it. Here is what you need to know, why it matters, and what to do about it.

When device risks aren't clearly communicated, patients pay the price. In the wake of sweeping FDA layoffs, BISA spoke out in MedTech Dive about how delayed safety alerts and missing recall notices could put lives at risk.

The MDIC released new guidance on using real-world data. As momentum builds around direct patient input, BISA offers practical recommendations to turn this progress into lasting safety, trust, and meaningful partnerships.

As the medical community discusses the latest on breast implant associated cancers, members of the Breast Implant Safety Alliance (BISA) are gathering patients and survivors to help amplify their powerful stories.

Groundbreaking research confirms that silicone can migrate into the body, even without a rupture, triggering inflammation, immune responses, and autoimmune markers. What does this mean for women with implants? The findings may change everything. Read more to find out.

SAVE THE DATE! The 6th World Consensus Conference on BIA-ALCL will be held April 11-12, 2025, and will feature leading experts in breast surgery and implant safety discussing the latest research on breast implant-associated cancers.

There has been some confusion regarding the Breast Surgery Collaborative Community (BSCC) consensus document and a separate statement issued by the American Society of Plastic Surgeons (ASPS) and The Aesthetic Society (ASAPS). To ensure clarity, BISA is providing this explanation to differentiate between the official BSCC work product and the joint statement released by the plastic surgery societies.

Women with breast implants have long reported lingering health issues—even after removal. Now, groundbreaking research reveals a possible culprit: residual silicone particles left behind in the body, triggering chronic inflammation. Could this be the missing link to unexplained symptoms? Here’s what you need to know.

The FDA plays a major role in deciding which medical devices are safe, but who ensures that patient voices are heard in those decisions? BISA’s own Maria Gmitro has been appointed as a Consumer Representative for the FDA, bringing real-world patient perspectives to the table. Read on to find out why this is a major win for patient advocacy!

Recognized on February 13th, Breast Implant Illness (BII) Awareness Day serves as a critical moment to highlight the struggles faced by individuals experiencing health complications related to breast implants.

On February 6, 2025, the FDA provided updates on the safety and effectiveness of breast implants. BISA provides a brief summary and why this info is crucial for the public.

Important news for women facing breast cancer! Support for including flat closure as a breast cancer reconstruction option was published by the Society of Surgical Oncology (SSO) in a new position statement.

The FDA recently removed web pages about diversity in clinical trials, medical device safety, and more. Many experts are worried that this will make it harder for people to find important health information.

Every woman is at risk for breast cancer. You never know when you or someone you love will be faced with decisions about breast implants. We want to keep you safe, healthy and informed with information you can trust. KNOWLEDGE IS BEAUTIFUL

As we welcome 2025, we remain committed to transparency, patient safety, and empowering women with the information they deserve. Take a peek at the links we want to start highlighting in 2025.